MMP-13 inhibition may thus have potential for the treatment of arthritis progression, and the K/BxN serum-induced arthritis model will serve as a useful tool to study the efficiency of MMP-13 inhibitors in treating arthritis. This evidence concerns the gene MMP13 and Arthritis.